Sanara Ventures
Overview
Sanara Ventures is a healthcare investment platform and incubator established in 2015 as a joint venture between Philips Healthcare and Teva Pharmaceuticals, focusing on seed and early-stage investments in digital health, medical devices, and bio-convergence.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TailorMed | Nov 2024 | Series B | - |
| Lydus Medical | May 2021 | Seed | Co-investor |
| Panacea-ml | Nov 2022 | Pre Seed | Co-investor |
| CVAid Medical | Feb 2022 | Series A | Co-investor |
| Nonagon Care | Apr 2021 | Accelerator | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Sanara Ventures based?
Sanara Ventures is headquartered in Ra'anana, Israel.
When was Sanara Ventures founded?
Sanara Ventures was founded in 2015.
How many portfolio companies does Sanara Ventures have?
Sanara Ventures has 5 portfolio companies in Caplight's dataset.
What are some companies in Sanara Ventures's portfolio?
Portfolio companies visible on Caplight include TailorMed, Lydus Medical, Panacea-ml, CVAid Medical, Nonagon Care.
What was Sanara Ventures's most recent investment shown here?
Sanara Ventures's most recent investment in this portfolio sample was in TailorMed in 2024.
What sectors does Sanara Ventures focus on?
Sanara Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Enterprise Software, Consumer & Commerce.
What company stages does Sanara Ventures focus on?
Sanara Ventures typically invests at the Early stage.
What is Sanara Ventures's AUM?
Sanara Ventures's assets under management are estimated between $160.0M and $170.0M.